Startup based in Germany, 2 tracked investors.
Based in Germany, Atriva Therapeutics is a startup founded in 2016. Brouky records 2 investors associated with the company.
Atriva Therapeutics is a clinical-stage biopharmaceutical company developing host-targeting inhibitors against respiratory viral infections.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.